Wird geladen...
Ruxolitinib for Myelofibrosis – An Update of Its Clinical Effects
Myelofibrosis (MF), associated with a Philadelphia chromosome-negative myeloproliferative neoplasms, is characterized by progressive bone marrow fibrosis and ineffective hematopoiesis. Clinical hallmarks include splenomegaly, anemia, and debilitating symptoms. In two randomized phase III studies, th...
Gespeichert in:
| Veröffentlicht in: | Clin Lymphoma Myeloma Leuk |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2013
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5556922/ https://ncbi.nlm.nih.gov/pubmed/24238036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2013.09.006 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|